Bipolar Disorder (Pediatric) Research Study: Treatment of Severe Mood Dysregulation

Join a Research Study: Bipolar Disorder

This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioural problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy, and not currently hospitalized, psychotic, or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17.

For more information, click here to visit the National Institute of Mental Health website or read the article NIMH Outreach Partnership Meeting

Ready to set up your medication reminder?

Never forget to take your medication again. Here’s How:

  1. Go to the app store on your iPhone or iPad
  2. Click on the Updates button in the bottom right-hand corner
  3. Find your SARDAA Health Storylines App and press Update
  4. Once updated, go into your SARDAA Health Storylines App and click on your Medication Tracker
  5. Press Update Medication, then add reminders for each of the medications listed
  6. Be amazed as you are reminded instantly at the time you indicated to take your medications

We are here to help you where you need assistance. Feel free to contact us at (844) 475-4637 to let us know how we can help you with SARDAA Health Storylines.

Scientists open the ‘black box’ of schizophrenia with dramatic genetic discovery

For the first time, scientists have pinned down a molecular process in the brain that helps to trigger schizophrenia. The researchers involved in the landmark study, which was published Wednesday in the journal Nature, say the discovery of this new genetic pathway probably reveals what goes wrong neurologically in a young person diagnosed with the devastating disorder.

The study marks a watershed moment, with the potential for early detection and new treatments that were unthinkable just a year ago, according to Steven Hyman, director of the Stanley Center for Psychiatric Research at the Broad Institute at MIT. Hyman, a former director of the National Institute of Mental Health, calls it “the most significant mechanistic study about schizophrenia ever.”imrs

To read the complete article in The Washington Post, please click here.

Study in mice shows how brain ignores distractions; NIH-supported scientists map out circuitry that may be involved in autism, ADHD, and schizophrenia

In a study of mice, scientists discovered that a brain region called the thalamus may be critical for filtering out distractions. The study, published in Nature and partially funded by the National Institutes of Health (NIH), paves the way to understanding how defects in the thalamus might underlie symptoms seen in patients with autism, attention deficit hyperactivity disorder (ADHD), and schizophrenia.

To know more, read the complete news release on Study in mice shows how brain ignores distractions _ National Institutes of Health (NIH).

Medicaid to Cover New Treatment for First Episode Psychosis Based on NIMH-Funded Research; Coordinated specialty care may become more readily available

On October 16, 2015, the Centers for Medicare and Medicaid Services (CMS) posted an informational bulletin to State Medicaid Directors about covering treatment for first episode psychosis. A key feature of this bulletin is CMS’ support for coordinated specialty care, the evidence-based treatment approach tested in the NIMH RAISE initiative.

To read the informational bulletin, please click here.

Tragic Results when Individuals with schizophrenia-related brain disorders are left to deteriorate until their actions provoke a police response

People with untreated mental illness are 16 times more likely to be killed during a police encounter than other civilians approached or stopped by law enforcement, according to our new study. “Overlooked in the Undercounted: The Role of Mental Illness in Fatal Law Enforcement Encounters” urges lawmakers to reduce loss of life and the many social costs associated with police shootings by enacting public policies that will restore the mental health system so that individuals with severe mental illness are not left to deteriorate until their actions provoke a police response.

To know more, view the study report overlooked-in-the-undercounted .

 

 

Do something to move your health forward today

Regardless of where you are and what’s holding you back, use today as the catalyst to move your care in the right direction. Whether it’s going for a walk, or just getting out of bed, put your health in the palm of your hands and do something to better yourself.

Studies show that keeping track of progress helps people make more progress. Continue to improve your life by taking advantage of your SARDAA Health Storylines tools and add a medication, track a symptom, journal about your day, or any of your other tools.

We are here to help you where you need assistance. Feel free to contact us at(844) 475-4637 to let us know how we can help you with SARDAA Health Storylines.

Distinct ‘Biotypes’ Identified That Cross Clinical Psychosis Diagnoses

Three neurobiologically distinct psychosis “biotypes” have been identified that appear to cross clinical diagnostic boundaries for schizophrenia, schizoaffective disorder, and bipolar disorder with psychosis, according to a report appearing online in AJP in Advance. The study illustrates how distinct neurobiological biotypes can, through multiple pathways, lead to clinically similar psychosis manifestations. And the findings may lead to more individualized treatment options, the authors say.

To read further, please click here to visit the Psychiatric News Website.

 

 

 

Advanced Training for Addiction and Mental Health Professionals

While addiction may be an equal-opportunity disease, it affects women differently than men especially with regard to co-occurring mental health conditions. Recognizing these differences can be critical in helping women find the most-effective diagnosis, care, and recovery support.

Hear leading experts share their insight, perspectives, experience, and hope at the Betty Ford Center’s 2016 Women’s Symposium–Living Your Truth.

March 24

University of California at Los Angeles
UCLA Carnesale Commons, Palisades Room
251 Charles E. Young Dr. W.
Los Angeles, CA 90095

$165 includes the all-day conference and lunch.

Registration: 7 a.m.-8 a.m.
Conference: 8 a.m.-3:45 p.m.

Click here to register online.

Post Columnist Defends Deeds’ Lawsuit, Cites My Blogs Warning About “Streeting”

Here’s a brief extract from an intriguing blog article by PETE EARLEY. To read the complete article, please click here.

Before anyone feels sorry for state mental health officials who are being sued by Virginia state Senator Creigh Deeds, they should do what my favorite columnist at The Washington Post has done. Take time to read several blogs that I wrote about an Inspector General report that was issued twenty-two months before Deeds was told there were no local mental health beds available and was sent home with his son, Gus, who desperately needed psychiatric treatment.

A fair-minded but tough state Inspector General named G. Douglas Bevelacqua wrote a damning report in 2012 that exposed how Virginia hospitals were  “streeting” psychotic patients. That was the term emergency room doctors used when they turned patients away because there were no crisis care beds available. Bevelacqua, who cared passionately about mental health reform, warned the state’s Department of Behavioral Health and Developmental Services that Virginia had a bed shortage problem that needed to be fixed. Immediately. No one listened.